Jennifer C. Price’s Ironwood Pharmaceuticals IRWD Stock Holding History

Jennifer C. Price’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-520,000	Closed	-$5.53M	–	56
2023 Q2	$5.53M	Hold	520,000	–	–	1.9%	19
2023 Q1	$5.47M	Hold	520,000	–	–	1.74%	21
2022 Q4	$6.44M	Hold	520,000	–	–	1.54%	25
2022 Q3	$5.39M	Hold	520,000	–	–	1.11%	31
2022 Q2	$6M	Buy	+520,000	New	+$6.13M	1.02%	31

Other funds holding IRWD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Jennifer C. Price's IRWD Position: Q3 2023 in Review

Jennifer C. Price sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2023, closing a stake of 520,000 shares — an estimated $5.53M sold.

Jennifer C. Price first reported a position in IRWD in Q2 2022 and held it in 5 quarters. The position peaked at $6.44M in Q4 2022. 248 funds tracked by Wall St. Rank hold IRWD as of Q3 2023.

Jennifer C. Price reported no remaining Ironwood Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
Jennifer C. Price sold 520,000 Ironwood Pharmaceuticals shares in Q3 2023, an estimated $5.53M.
Jennifer C. Price first reported a position in Ironwood Pharmaceuticals in Q2 2022 and held it in 5 quarters.
Jennifer C. Price's Ironwood Pharmaceuticals position peaked at $6.44M in Q4 2022.
248 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2023.

Based on Jennifer C. Price's 13F filing for Q3 2023, filed 14 Nov 2023.